Vikas Gupta

We are pleased to announce the Pancreatic Surgery Masterclass @ACTREC_TMC on 11th April 2026. One-day immersive program is focused purely on operative technique, decision-making in high-risk pancreas, and video-based technical discussions. Registration- forms.gle/TfmdTRAwHmiv8q…

IVC sarcomas... Involving Bilateral renal ostia!!! Do we really need to reconstruct??? Resection without reconstruction... our standard procedure Left renal vein drainage🤔 Collaterals almost always reliable👍 More than 50 cases.. Excellent outcomes!! 3 cases over last 2 weeks!

🎯 NEW: T-MOD PD Classification Finally—a framework that asks the RIGHT questions after pancreatoduodenectomy death. Beyond Binary Mortality Endpoints: journals.lww.com/annalsofsurger… @Shrikhande_SV @DrVAChaudhari @Manishbhandare4 @DrGuruduttVarty @TataMemorial @IHPBA @AnnalsofSurgery

🏆 Big win at #APHPBA2025! The POLCAGB Trial clinches Best Paper Award at the Plenary Session! 💡 Concurrent chemoradiation + chemotherapy shows improved survival & resection outcomes in locally advanced gallbladder cancer. @shraddha_234 @APHPBA

@Manishbhandare4 @TataMemorial @ACTREC_TMC @Shrikhande_SV @DrVAChaudhari @aamirparray18 @MufaddalKazi @dnair78 Congratulations and well deserved sir!!👏👏

Humbled to be recognized with the Best Teacher Award, dedicated to all my students and teachers and colleagues @TataMemorial @ACTREC_TMC @Shrikhande_SV @DrVAChaudhari @aamirparray18 And congrats @MufaddalKazi @dnair78 and DrVirendra as well for receiving best teacher’s award.

Intra operative revision of +ve margin ⬆️ survival in gastric & GE junction adenoCa ✔️ R0 resection remains crucial ✔️ Even in locally advanced cases, margin revision improves outcomes—esp. in N0/N1 disease 🔗 doi.org/10.1016/j.gass… @Shrikhande_SV @JournalofGISurg @timpawlik

@Shrikhande_SV @TataMemorial @DAEIndia @ACTREC_TMC @RCSEd Congratulations sir!!👏👏

Truly humbled and privileged to receive the Fellowship ad hominem. Huge honour dedicated to my patients and colleagues @TataMemorial @DAEIndia @ACTREC_TMC and my parents 🙏🏻@RCSEd

Introducing "MASTERY OF SURGERY" by IASO Academics. This is a unique platform to avail expert videos by experienced surgeons. We aim to provide a step by step tutorial for trainees which will reduce morbidity and improve patient care. #surgery #video #Training #Oncology #IASO

@Shrikhande_SV @AmCollSurgeons @TataMemorial Congratulations @Shrikhande_SV sir , a well deserved honour !!

Receiving the Honorary fellowship of ⁦@AmCollSurgeons⁩ is a heartfelt tribute to my late father. He was more than a father to me whose values will continue to guide me for eternity! Grateful to my patients ⁦@TataMemorial⁩ and my family for unending love and support!

Delighted to work and guide this document alongside with a world class panel of experts! @APHPBA @IHPBA @EAHPBA @DrPJagannath @DrVAChaudhari @ItaruEndo @JSHBPS

Satisfying when years of hardwork under the leadership of Prof. @drmgoel and Prof. @Shraddha_234 culminates into this. Excellent work by @Kaival_Gundavda 'Textbook Outcome' (TO) following liver resection for hepatic neoplasms Link to full article link.springer.com/article/10.124…

CA 19-9 is of great value in Ampullary cancers too Should be a routine surveillance test Our work to feature in @AnnalsofSurgery for the 1st time, hoping this to be a good beginning @DrGuruduttVarty special congratulations to you 🤝👍 journals.lww.com/annalsofsurger… @Shrikhande_SV

Join us tomorrow- IASG NCG Tumor Boards - Pancreatic Cancer - 9.8.2024 , 7.30 pm. Link - iecho.org/public/program… @cspramesh @gvraoaig @Shrikhande_SV @aamirparray18 @AnantRamaswamy @Dr_AkshayBaheti

Prognostic impact of isolated para-aortic LN metastasis in periampullary cancer: Surgical resection or reconsideration? Recently published @AnnSurgOncol link.springer.com/article/10.124… Grateful for the opportunity 🙏 @DrVAChaudhari @Shraddha_234 @Manishbhandare4 @Shrikhande_SV

A pleasure to conceptualize and lead this effort thanks to the fine inputs of so many pancreas surgery experts from around the world! @Gio_Marchegiani @sgeorgebarreto @JorgKleeff

IASG NCG collaboration GI Oncology Tumor Boards. Please join us today at 7.30 PM IST echo.zoom.us/j/88556299498

CA 19-9 in PDAC, when do you say no to surgery even when technically feasible? Degree of response to NAT and the absolute cut-off level, both matter.. check our paper @hpbjournal @ProfW_edinsurg authors.elsevier.com/a/1jLE9,V2cWFt… Strong work @docvikasgupta @Shrikhande_SV @DrVAChaudhari

-Minimal handling -Identify and close ☝️Best strategy to minimize pancreatic occusion failure..Do you agree? @IHPBA @EAHPBA @Shrikhande_SV @DrVAChaudhari @hpbsurgeon1 @SyedAAhmad5 @DrPJagannath

@Hepbilisurg_TMH @Shraddha_234 @AnnSurgOncol @McMastersKelly @alegronchi @SBonvalot @cspramesh @docdcruz @Sarcoma_UK @anantmdesai @docgulia Young professor of my team at TMH -Dr Shraddha Patkar was chosen by me to lead and establish this as a MDT speciality in 2017. The paper is the culmination of 7 years of hardwork and dedication. This puts us on the world map as the biggest centre in Asia

Glad to share the largest study from India on RP sarcomas. Year 2017, when a dedicated RP tumor service began at TMH under the leadership of @drmgoel. @Shraddha_234 led the MDT with inception of 'RP Clinic' in 2018. This puts us on the world map! Link 👇🏽 link.springer.com/article/10.124…